HIV Vaccine Awareness Day
WHO announces priority endemic pathogens for urgent vaccine development
The study identifies the 17 pathogens that regularly cause diseases in communities
Valneva and LimmaTech Biologics partner to advance Shigella vaccine candidate
There is currently no vaccine approved for Shigella, the second leading cause of fatal diarrhoeal disease globally
WHO announces new mRNA vaccine development initiative against human avian influenza
H5N1 was responsible for 889 cases and 463 deaths across 23 countries from 2003 to 2024
GSK and Flagship Pioneering partner in deal worth up to $7bn to discover medicines and vaccines
The companies aim to develop a portfolio of up to ten candidates
UKHSA and The Pirbright Institute collaborate to develop vaccines against henipaviruses
There are currently no licensed vaccines or treatments for the Nipah virus
AstraZeneca announces plans to invest £650m in UK to boost life sciences sector
The investment will also help to enhance public health protection and pandemic preparedness in the UK
New nanoparticle to deliver vaccines and generate strong immune responses at lower dose
MOF activates the innate immune system through TLRs to provoke strong immune responses
GSK partners with DNA specialist Elegen to advance medicines and vaccines
GSK will leverage Elegen’s cell-free synthetic DNA production technology
New WHO initiative to prioritise endemic pathogens for vaccine development
Value profiles of 16 pathogens with vaccines in clinical development will be featured
Moderna and CEPI enter pandemic preparedness partnership
The partnership aims to expand infectious disease targets for mRNA vaccine technology
Differences in immune responses could optimise future COVID-19 vaccines
Vulnerability to different mutations was linked to previous infections and vaccination
